Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback